1.Can Localized Stenosis of the Main Pancreatic Duct be a Predictive Factor for Early Detection of Pancreatic Cancer?
Mamoru TAKENAKA ; Kentaro YAMAO ; Masatoshi KUDO
Clinical Endoscopy 2019;52(6):523-524
No abstract available.
Constriction, Pathologic
;
Pancreatic Ducts
;
Pancreatic Neoplasms
2.Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis
Ryota SAGAMI ; Kentaro YAMAO ; Ryuki MINAMI ; Jun NAKAHODO ; Hidetoshi AKIYAMA ; Hidefumi NISHIKIORI ; Kazuhiro MIZUKAMI ; Kenji YAMAO ; Vikram BHATIA ; Yuji AMANO ; Kazunari MURAKAMI
Gut and Liver 2024;18(2):338-347
Background/Aims:
High-grade pancreatic intraepithelial neoplasia and invasive pancreatic duc-tal adenocarcinoma ≤10 mm are targets for early detection of pancreatic cancer. However, their imaging characteristics are unknown. We aimed to identify endoscopic ultrasound findings for the detection of these lesions.
Methods:
Patients diagnosed with high-grade pancreatic intraepithelial neoplasia (n=29), pan-creatic ductal adenocarcinoma ≤10 mm (n=11) (who underwent surgical resection), or benignmain pancreatic duct stenosis (n=20) between January 2014 and January 2021 were retrospectively included. Six features differentiating these lesions were examined by endoscopic ultraso-nography: main pancreatic duct stenosis, upstream main pancreatic duct dilation, hypoechoic areas surrounding the main pancreatic duct irregularities (mottled areas without demarcation or round areas with demarcation), branch duct dilation, prominent lobular segmentation, and atrophy. Interobserver agreement was assessed by two independent observers.
Results:
Hypoechoic areas surrounding the main pancreatic duct irregularities were observedmore frequently in high-grade pancreatic intraepithelial neoplasia (82.8%) and pancreatic ductal adenocarcinoma ≤10 mm (90.9%) than in benign stenosis (15.0%) (p<0.001). High-grade pan-creatic intraepithelial neoplasia exhibited mottled hypoechoic areas more frequently (79.3% vs 18.9%, p<0.001), and round hypoechoic areas less frequently (3.4% vs 72.7%, p<0.001), than pancreatic ductal adenocarcinoma ≤10 mm. The sensitivity and specificity of hypoechoic areas for differentiating high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarci-noma ≤10 mm, and benign stenosis were both 85.0%, with moderate interobserver agreement.
Conclusions
The hypoechoic areas surrounding main pancreatic duct irregularities on endo-scopic ultrasound may differentiate between high-grade pancreatic intraepithelial neoplasia, pan-creatic ductal adenocarcinoma ≤10 mm, and benign stenosis (Trial Registration: UMIN Clinical Trials Registry (UMIN000044789).
3.New endoscopic ultrasonography techniques for pancreaticobiliary diseases.
Ken KAMATA ; Masayuki KITANO ; Shunsuke OMOTO ; Kumpei KADOSAKA ; Takeshi MIYATA ; Kosuke MINAGA ; Kentaro YAMAO ; Hajime IMAI ; Masatoshi KUDO
Ultrasonography 2016;35(3):169-179
Endoscopic ultrasonography (EUS) is widely used to evaluate pancreaticobiliary diseases, especially pancreatic masses. EUS has a good ability to detect pancreatic masses, but it is not sufficient for the differential diagnosis of various types of lesions. In order to address the limitations of EUS, new techniques have been developed to improve the characterization of the lesions detected by EUS. EUS-guided fine needle aspiration (EUS-FNA) has been used for diagnosing pancreatic tumors. In order to improve the histological diagnostic yield, a EUS-FNA needle with a core trap has recently been developed. Contrast-enhanced harmonic EUS is a new imaging modality that uses an ultrasonographic contrast agent to visualize blood flow in fine vessels. This technique is useful in the diagnosis of pancreatic solid lesions and in confirming the presence of vascularity in mural nodules for cystic lesions. EUS elastography analyzes several different variables to measure tissue elasticity, color patterns, and strain ratio, using analytical techniques such as hue-histogram analysis, and artificial neural networks, which are useful for the diagnosis of chronic pancreatitis and pancreatic cancer.
Biliary Tract
;
Biopsy, Fine-Needle
;
Diagnosis
;
Diagnosis, Differential
;
Elasticity
;
Elasticity Imaging Techniques
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration
;
Endosonography*
;
Needles
;
Pancreas
;
Pancreatic Neoplasms
;
Pancreatitis, Chronic
4.Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer
Kunio KATAOKA ; Eizaburo OHNO ; Takuya ISHIKAWA ; Kentaro YAMAO ; Yasuyuki MIZUTANI ; Tadashi IIDA ; Hideki TAKAMI ; Osamu MAEDA ; Junpei YAMAGUCHI ; Yukihiro YOKOYAMA ; Tomoki EBATA ; Yasuhiro KODERA ; Hiroki KAWASHIMA
Clinical Endoscopy 2024;57(1):112-121
Background/Aims:
Since the usefulness of neoadjuvant chemo(radiation) therapy (NAT) for pancreatic cancer has been demonstrated, recurrent biliary obstruction (RBO) in patients with pancreatic cancer with a fully covered self-expandable metal stent (FCSEMS) during NAT is expected to increase. This study investigated the impact of sarcopenia on RBO in this setting.
Methods:
Patients were divided into normal and low skeletal muscle index (SMI) groups and retrospectively analyzed. Patient characteristics, overall survival, time to RBO (TRBO), stent-related adverse events, and postoperative complications were compared between the two groups. A Cox proportional hazard model was used to identify the risk factors for short TRBO.
Results:
A few significant differences were observed in patient characteristics, overall survival, stent-related adverse events, and postoperative complications between 38 patients in the normal SMI group and 17 in the low SMI group. The median TRBO was not reached in the normal SMI group and was 112 days in the low SMI group (p=0.004). In multivariate analysis, low SMI was the only risk factor for short TRBO, with a hazard ratio of 5.707 (95% confidence interval, 1.148–28.381; p=0.033).
Conclusions
Sarcopenia was identified as an independent risk factor for RBO in patients with pancreatic cancer with FCSEMS during NAT.
5.Bispectral index-guided propofol sedation during endoscopic ultrasonography
Ayana OKAMOTO ; Ken KAMATA ; Takeshi MIYATA ; Tomoe YOSHIKAWA ; Rei ISHIKAWA ; Tomohiro YAMAZAKI ; Atsushi NAKAI ; Shunsuke OMOTO ; Kosuke MINAGA ; Kentaro YAMAO ; Mamoru TAKENAKA ; Yasutaka CHIBA ; Toshiharu SAKURAI ; Naoshi NISHIDA ; Masayuki KITANO ; Masatoshi KUDO
Clinical Endoscopy 2022;55(4):558-563
Background/Aims:
Bispectral index (BIS) monitors process and display electroencephalographic data are used to assess the depth of anesthesia. This study retrospectively evaluated the usefulness of BIS monitoring during endoscopic ultrasonography (EUS).
Methods:
This study included 725 consecutive patients who underwent EUS under sedation with propofol. BIS monitoring was used in 364 patients and was not used in 361. The following parameters were evaluated: (1) median dose of propofol; (2) respiratory and circulatory depression; (3) occurrence of body movements; (4) awakening score >8 at the time; and (5) awakening score 2 hours after leaving the endoscopy room.
Results:
The BIS group received a significantly lower median dose of propofol than the non-BIS group (159.2 mg vs. 167.5 mg; p=0.015) in all age groups. For patients aged ≥75 years, the reduction in heart rate was significantly lower in the BIS group than in the non-BIS group (1.2% vs. 9.1%; p=0.023). Moreover, the occurrence of body movements was markedly lower in the BIS group than in the non-BIS group (8.5% vs. 39.4%; p<0.001).
Conclusions
During EUS examination, BIS monitoring is useful for maintaining a constant depth of anesthesia, especially in patients 75 years of age or older.